CD33 and Alzheimer disease: GWAS studies have indicated the importance of the microglial phagocytic receptors TREM2 and CD33 in the pathogenesis of AD (Griciuc and Tanzi, 2021), and this has been core to the concept of neuroinflammation as a driver of AD.